Share Name Share Symbol Market Type Share ISIN Share Description
Braveheart Inv LSE:BRH London Ordinary Share GB00B13XV322 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -3.33% 14.50p 14.00p 15.00p 15.00p 14.50p 15.00p 47,792 09:48:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.1 -1.7 -6.2 - 3.92

Braveheart Investment (BRH) Latest News

More Braveheart Investment News
Braveheart Investment Takeover Rumours

Braveheart Investment (BRH) Share Charts

1 Year Braveheart Investment Chart

1 Year Braveheart Investment Chart

1 Month Braveheart Investment Chart

1 Month Braveheart Investment Chart

Intraday Braveheart Investment Chart

Intraday Braveheart Investment Chart

Braveheart Investment (BRH) Discussions and Chat

Braveheart Investment Forums and Chat

Date Time Title Posts
09/2/201712:31Braveheart Investment Group 201278
09/2/201212:31BRAVEHEART: PURE VALUE36
09/2/201211:08BRAVEHEART INV GROUP ;;;; Uni Funds23

Add a New Thread

Braveheart Investment (BRH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2017-05-25 12:10:3514.992,500374.75O
2017-05-25 09:37:0615.0026,6073,991.05O
2017-05-25 09:26:0914.2515,8852,263.61O
2017-05-25 08:48:1914.252,712386.46O
2017-05-25 07:03:1214.258812.54O
View all Braveheart Investment trades in real-time

Braveheart Investment (BRH) Top Chat Posts

DateSubject
25/5/2017
09:20
Braveheart Investment Daily Update: Braveheart Inv is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BRH. The last closing price for Braveheart Investment was 15p.
Braveheart Inv has a 4 week average price of 13.75p and a 12 week average price of 13.75p.
The 1 year high share price is 22.88p while the 1 year low share price is currently 5.50p.
There are currently 27,055,491 shares in issue and the average daily traded volume is 57,270 shares. The market capitalisation of Braveheart Inv is £3,923,046.20.
09/1/2017
22:04
swizz: bf, welcome aboard and good to have another poster, unfortunately TB is not at his best during media interviews, which is in complete contrast when he is one to one, the turn around since TB took the reigns is seriously impressive and bodes well for the future, there is some great things happening at Kirkstall, Paraytec, DI4D, Pyreos, Gyrometric, Viking, Vascular Flow, with the added bonus that everyone of them is producing and generating revenue, .....GL S Braveheart Investment keeping the momentum going INVESTMENT OVERVIEW: BRH THE BIG PICTURE Braveheart seeks to back nascent technology companies and work closely with their boards It is hard sometimes to value an investment company like Braveheart Investment Group PLC (LON:BRH), which plays the long game, backing promising technology businesses. Then, along comes a “value realisation” moment, as they call it in the trade, and things get a bit clearer. Such was the case in July, when the company announced it was in advanced talks to dispose of a stake in one of its investee companies, mLED Limited. The share price doubled, and though it came off the boil after the sales was confirmed in September, the shares are still up a very handy 77% over the last year. The group has a 1.25% direct holding and 3.75% stake held through subsidiary Strathclyde Investment Fund in mLED. Proceeds from the sale were £399,000 in cash compared to a book value of £96,000. The money went in the kitty, to invest in more promising technology companies. Talking of which … shares were on the rise again in January 2017 as the company took a 47% stake in Gyrometric Systems Limited, an engineering firm using technology developed at Nottingham Trent University. Gyrometric provides monitoring technology that measures the performance of drive shafts in a wide variety of applications. In effect, the technology tunes the devices, enabling them to operate at maximum efficiency, thereby saving energy, maintenance and capital costs. The large stake taken by Braveheart represents a continuation of the change of strategy by Braveheart, with the company gaining in confidence and backing its judgement more heavily. Not that Gyrometric seems like a particularly risky investment. Braveheart said Gyrometric already has established sales partners in Germany and Asia on which it will now build and expects to break-even in 2017. Selling a stake in a company provides a nice occasional bonus for the company, but the steady income is provided by its wholly-owned subsidiary, Viking Fund Managers. Viking's main fund management income comes from the Finance Yorkshire Equity Fund contract, but it also provides specialist fund management services to other funds that are in 'run-out' mode. This specialised management work tends to generate enhanced fees in excess of standard fund management fees due to the intensive nature of this work. The emphasis for the FYEF is now on portfolio management rather than in seeking new investments and the unit is seeking to win the management contracts for further funds. Viking was recently awarded an additional sum of £2 million of new capital to invest through the existing FYED contract, which means that the investment phase of this contract has been extended into 2017 – March, to be precise. Once this extended investment phase of the contract is completed, Viking will concentrate on realising fund investments with this part of the management contract expected to be completed during 2019. Viking was not successful in winning a fund management contract for the initial phase of the new Northern Powerhouse Investment Fund initiative; however it continues to work with a number of third parties with a view to gaining new fund management contracts. Interim results for the whole group released in October revealed costs were cut in half from a year earlier, which meant pre-tax profits for the six months to September 30 of £475,000 were the largest since the company floated more than eight years ago. They were achieved on revenues of £562,000 and compared with a loss in the comparable period last year of just over £1mln. Overheads fell from £868,000 to £435,000. The comp recently took on 33% of Paraytec, a York-based scientific instruments specialist, and 28% of Kirkstall, which makes equipment for cell tissue labs. Both companies are performing well, either meeting or exceeding internal targets set for them. Sales have now begun of Paraytec's ActiPix D200 system, which was recently introduced into the global pharmaceutical market, Braveheart revealed. Sirius Analytical, one of the first ActiPix licensees, has successfully launched a new drug dissolution imager, incorporating ActiPix technology. It has already met with strong interest from global research laboratories that are interested in licensing the ActiPix wizardry, Braveheart said. The royalties generated from such licences are expected to comprise the majority of Paraytec's future income. Meanwhile, sales of Kirkstall’s 'organ-on-a-chip` system, Quasi Vivo, are ahead of forecast. Research group Research and Markets estimates that the global `organ-on-a-chip` market is poised to grow at a compound annual growth rate of around 69% over the next decade to reach about US$6.13 billion by 2025.
09/2/2012
11:08
samuelchristo: Good afternoon all - I posted this on another thread: If I may I'd like to bring people's attention to Braveheart Investment Group (BRH). I feel the stock is now highly undervalued with a sub £2 million market cap. They have a NAV of 28p with a current share price of 10p. They have around £800,000 cash. They are invested in 23 quality companies who they will work each towards a profitable exit. I feel the share-price will quickly double and more during 2012. There will be plenty of newsflow due to the number of maturing companies they are working toward IPOs on. The chart isn't pretty but I feel this is due a bounce very soon. I have set up a new thread http://uk.advfn.com/cmn/fbb/thread.php3?id=26950477 with further information and links to their 23 investments. All are welcome. This is all my opinion and not intended to be investment advice. Thanks for your time. SC
Braveheart Investment share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20170526 03:27:44